Do peptides need to be refrigerated?
Lyophilised (dry-form) peptides do not strictly need refrigeration for short-term storage — controlled room temperature (15-25 °C, dry, dark) is acceptable for 4-8 week windows. Refrigeration (2-8 °C) is the default for longer-term holding of unopened vials and is required for post-reconstitution working-solution storage between draws.
What the research literature says
The lyophilised dry form of a peptide is dramatically more stable than the aqueous reconstituted form. The Wang lyophilisation review consolidates the physical-chemistry basis: removing water eliminates the substrate for most peptide-degradation pathways including hydrolysis, deamidation, and aggregation (PMID 10967427). The Tang-Pikal freeze-drying-processes work covers the production-cycle parameters that translate into post-lyophilisation stability (PMID 15032301).
Three storage tiers apply to research peptides: (1) Controlled room temperature for short-term holding of unopened vials — adequate for the 4-8 week window between manufacture, shipping, and immediate research use. (2) Refrigerated storage at 2-8 °C for stated multi-year shelf life on unopened commercial vials. (3) Frozen storage at -20 °C or -80 °C for long-term archival of unopened vials and for aliquoted reconstituted peptide in single-use portions.
The operational point: lyophilised stocks ship at ambient or refrigerated temperatures rather than frozen, simplifying logistics. Researchers receiving a shipment can transition the unopened vials into refrigerated storage on arrival without concern about cold-chain breaks during transit. Post-reconstitution, the picture changes — the reconstituted aqueous solution is far less forgiving and benefits from refrigerated working-storage between draws.
Why this matters in research context
The relaxed cold-chain requirement for lyophilised peptides is the operational advantage that drives the dry-form supply default. Researchers don’t need to maintain unbroken refrigerated chain during shipping or short-term storage; the sealed-vial inert-gas-headspace integrity is the primary stability mechanism. Post-reconstitution practice tightens — the reconstituted solution should be refrigerated between draws or aliquoted and frozen for multi-month protocols.
Related compounds
- Peptide storage guide — full pre-reconstitution and post-reconstitution storage protocols
Related research questions
- How do you store lyophilized peptides?
- What is the shelf life of lyophilized peptides?
- Can you freeze reconstituted peptides?
References
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 2000;203(1-2):1-60. [PMID 10967427]
- Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res 2004;21(2):191-200. [PMID 15032301]
- ICH Q1A(R2) — Stability Testing of New Drug Substances and Products. Container/closure considerations for shelf-life claims. International Council for Harmonisation.
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.